Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.520
-0.060 (-2.33%)
Jul 25, 2025, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.22 billion as of July 25, 2025. Its market cap has increased by 155.67% in one year.
Market Cap
3.22B
Enterprise Value
3.37B
Revenue
9.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.52
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.22B, an increase of 4,110.83%. That is a compound annual growth rate of 19.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 3.22B | -9.27% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | 1.32B | 19.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.52B |
| Pro Medicus | 33.42B |
| Cochlear | 20.46B |
| Sonic Healthcare | 14.00B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 7.10B |
| Ansell | 4.50B |
| Regis Healthcare | 2.40B |